Evidence map›Paper›PMID 18550766›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2008

Age-dependent neurodegeneration accompanying memory loss in transgenic mice defective in mitochondrial aldehyde dehydrogenase 2 activity.

Ikuroh Ohsawa, Kiyomi Nishimaki, Yayoi Murakami, Yuko Suzuki, Masahiro Ishikawa, Shigeo Ohta

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 2 pooled it
5.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 2 syntheses or guidelines pooled it, 117 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. The role ofFrontiers in neuroscience · 2024
    Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Transcriptional Silencing ofCancer discovery · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Regulatory Roles of Bone in Neurodegenerative Diseases.Frontiers in aging neuroscience · 2020
    Review
  17. Article
  18. Article
  19. Article
  20. Environmental Aldehyde Sources and the Health Implications of Exposure.Advances in experimental medicine and biology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ikuroh OhsawaDepartment of Biochemistry and Cell Biology, Institute of Development and Aging Sciences, Graduate School of Medicine, Nippon Medical School, Kawasaki 211-8533, Japan.
Kiyomi Nishimaki
Yayoi Murakami
Yuko Suzuki
Masahiro Ishikawa
Shigeo Ohta
Nippon Medical School · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxidative stress may underlie age-dependent memory loss and cognitive decline. Toxic aldehydes, including 4-hydroxy-2-nonenal (HNE), an end product of lipid peroxides, are known to accumulate in the brain in neurodegenerative disease. We have previously shown that mitochondrial aldehyde dehydrogenase 2 (ALDH2) detoxifies HNE by oxidizing its aldehyde group. To investigate the role of such toxic aldehydes, we produced transgenic mice, which expressed a dominant-negative form of ALDH2 in the brain. The mice had decreased ability to detoxify HNE in their cortical neurons and accelerated accumulation of HNE in the brain. Consequently, their lifespan was shortened and age-dependent neurodegeneration and hyperphosphorylation of tau were observed. Object recognition and Morris water maze tests revealed that the onset of cognitive impairment correlated with the degeneration, which was further accelerated by APOE (apolipoprotein E) knock-out; therefore, the accumulation of toxic aldehydes is by itself critical in the progression of neurodegenerative disease, which could be suppressed by ALDH2.

Indexed as

AgingAldehyde DehydrogenaseAldehyde Dehydrogenase, MitochondrialAldehydesAnalysis of VarianceAnimalsBehavior, AnimalCells, CulturedCerebral CortexEmbryo, MammalianExploratory BehaviorGene Expression Regulation, DevelopmentalHumansIn Situ Nick-End LabelingMaze LearningMemory Disorders4-hydroxy-2-nonenalAldehyde DehydrogenaseAldehyde Dehydrogenase, MitochondrialAldehydesALDH2 protein, mouseNerve Tissue ProteinsPeptide Elongation Factor 1

Identifiers

PMID18550766
PMCPMC6670537
OpenAlexW2015032101

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.